Riskpilot← Back to searchSign inGet full accessEFB HOLDING AS
ASActiveOrg 997146549Brageveien 7, 1357 BekkestuaGeneral medical practice activities · NACE 8621Est. 20112 employees
Revenue 2024
NOK 4,4M
+1% vs 2023
EBITDA margin
35.5%
+18% vs 2023
Equity ratio
92.9%
Financial strength
Net profit 2024
NOK 651K
-14% vs 2023
| Revenue | NOK 4,4M | +1% |
| EBITDA | NOK 1,6M | +18% |
| Net profit | NOK 651K | -14% |
| Total assets | NOK 7,8M | +12% |
| Equity | NOK 7,3M | +10% |
| Employees | 2 | — |
Legal name
EFB HOLDING AS
Org number
997146549
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
9. august 2011
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Spesilistlegetjenste, investeringer i eiendommer og drift av disse, kjøp og slag av aksjer og verdipapirer og alt som står i denne forbindelse.
Address
Brageveien 7, 1357 Bekkestua
Phone
+4746893389
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 836 | 4 078 | 4 167 | 4 401 | 4 446 |
| Staff expenses | −233 | −58 | −655 | −440 | −463 |
| EBITDA | 1 558 | 1 809 | 1 054 | 1 336 | 1 577 |
| Depreciation & amort. | −189 | −387 | −389 | −389 | −779 |
| EBIT | 1 369 | 1 422 | 665 | 947 | 798 |
| Net financials | −12 | −5 | −2 | 27 | 56 |
| Profit before tax | 1 357 | 1 417 | 663 | 973 | 853 |
| Tax | 299 | 107 | 146 | 214 | 202 |
| Net profit | 1 058 | 1 309 | 517 | 759 | 651 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 624 | 5 890 | 6 198 | 6 994 | 7 832 |
| Equity | 4 036 | 5 345 | 5 862 | 6 621 | 7 280 |
| Long-term debt | 564 | 296 | 102 | 59 | −13 |
| Short-term debt | 24 | 249 | 234 | 314 | 566 |
| Total debt | 588 | 545 | 336 | 373 | 552 |
EBITDA margin
35.5%
This company
15.8%
Market median
+125% vs market
20202024
Equity ratio
92.9%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
8.9%
This company
18.4%
Market median
-52% vs market
20202024
Net profit margin
14.6%
This company
8.1%
Market median
+80% vs market
20202024
Asset turnover
0.57×
This company
1.12×
Market median
-49% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MF Deputy Member | Deputy Member | 2011 |
EF Chief Executive Officer | Chief Executive Officer | 2011 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EFB HOLDING AS 
COLOSSEUM ØYELEGESENTER ASBoard members of EFB HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Finnøy Bakke | Deputy Member | 0 companies |
| Espen Finnøy Bakke | Chief Executive Officer | 0 companies |